195 results about "Pulmonary embolism" patented technology

An inferior vena cava filter (340) for use in the inferior vena cava (4) to capture thrombus (8) passing through the inferior vena cava (4) towards the heart and lungs to prevent pulmonary embolism comprises a proximal support hoop (302), a distal support hoop (312) and a plurality of support struts (303) extending between the proximal support hoop (302) and the distal support hoop (312). The filter (340) also comprises a plurality of capture arms (121) which are movable from a capturing configuration to an open configuration. The capture arms (121) are biased towards the open configuration. A biodegradable suture holds the capture arms (121) in the capturing configuration.

An intravascular emboli capture and retrieval system for intravascular embolism protection and embolism removal or maceration. Guidewire mounted proximally and distally located multiple opening filters are deployed within the vasculature and used to part, divide and macerate embolic debris and to capture such embolic debris within the confines thereof. A deployable flexible preformed memory shaped capture sleeve is alternatively used to collapse one or more filters and embolic debris therein for subsequent proximal withdrawal from the vasculature.

The present invention relates to the use of carbon monoxide (CO) as a biomarker and therapeutic agent of heart, lung, liver, spleen, brain, skin and kidney diseases and other conditions and disease states including, for example, asthma, emphysema, bronchitis, adult respiratory distress syndrome, sepsis, cystic fibrosis, pneumonia, interstitial lung diseases, idiopathic pulmonary diseases, other lung diseases including primary pulmonary hypertension, secondary pulmonary hypertension, cancers, including lung, larynx and throat cancer, arthritis, wound healing, Parkinson's disease, Alzheimer's disease, peripheral vascular disease and pulmonary vascular thrombotic diseases such as pulmonary embolism. CO may be used to provide anti-inflammatory relief in patients suffering from oxidative stress and other conditions especially including sepsis and septic shock. In addition, carbon monoxide may be used as a biomarker or therapeutic agent for reducing respiratory distress in lung transplant patients and to reduce or inhibit oxidative stress and inflammation in transplant patients.

The present invention relates to a device that can be used to prevent embolisms from accessing the brain and causing a stroke. The device can also prevent pulmonary embolism and to treat an aneurysm. The device provides a significant improvement to any similar devices currently in use.

This invention provides a mechanical lower extremity manipulation device to increase venous blood flow in lower extremities for the prevention of deep vein thrombosis (DVT), pulmonary embolism (PE), lower extremity edema, and other associated or related conditions. Foot plates pivoting on a base plate can be powered to provide a reciprocating action to the feet of a reclining patient. Straps can hold the patient's legs against the base plate so that the reciprocating action results in alternate planar flexion and dorsal flexion of the foot without movement of the leg in general. The resulting elongation and retraction of lower leg muscles can improve venous blood flow to reduce the risk of pathologies, such as DVT.

The invention describes a method to automatically controlling, single channel Neuromuscular Electrical Stimulation (NMES) of the plantar muscle, in response to the sensing of motion of the foot or leg: to reduce accommodation of the stimulated plantar muscle and attendant reduction of contractions, which when undiminished increase blood flow for the prevention of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE); to turn off the stimulation during walking or running to prevent slips or falls; and to reduce power consumption of the unit that provides the stimulation.

A method and apparatus for treating a clot in the blood vessel of a patient, and particularly the treatment of a pulmonary embolism is disclosed. The treatment includes restoring flow through the clot followed by clot removal, either partially or substantially completely. The clot treatment device is expandable into the blood vessel and may contain radial extensions that assist in restoring flow as well as in removing clot material.

Aiming at the conditions that heparin has severe bleeding side effects in clinical practice and clinical application thereof is restricted, the invention discloses a technique for producing ultra-low molecular heparin sodium (calcium). The technique comprises the following steps of: taking heparin sodium solution, adding sodium nitrite solution for cracking; adjusting the lysis buffer by using alkaline; absorbing impurities by using an anion-exchange column; washing for obtaining ultra-low molecular heparin calcium; carrying out filtration by using an ultrafiltration membrane and obtaining a precipitate by using alcohol; and after desalting, dehydration, re-precipitation, cooling and drying, obtaining a finished product of ultra-low molecular heparin calcium. The product has better and safer antithrombotic effect under low level of anticoagulation, and can be widely used for preventing and treating diseases such as deep vein thrombosis, pulmonary embolism, disseminated intravascular coagulation, and the like.

A system and method for detecting an area of interest such as a pulmonary embolism in a structure of interest such as a vessel tree or airway tree are provided. The method comprises: segmenting image data of the structure of interest; and rendering two-dimensional images based on a function of the image data and the segmented image data within slabs defined by the segmented image data.

A method and apparatus for determining the presence or absence of a pulmonary embolism (PE) in a patient. The breathing gas CO₂ partial pressure (PCO₂) during the expiration of breathing gases by the patient, the end tidal (EtCO₂), CO₂ partial pressure, and the CO₂ partial pressure (PaCO₂) of the blood are measured. The volume (V) of breathing gases expired during the expiration of breathing gases by the patient is also measured and a relationship between changes in breathing gas CO₂ partial pressure (PCO₂) and changes in breathing gas volume (V) in an alveolar expiration phase of patient expiration is determined. The difference between the blood CO₂ partial pressure (PaCO₂) and the end expiration CO₂ partial pressure is divided by the relationship between PCO₂ and V produce a quantity which is compared to a threshold value. If the quantity is below the threshold value, the absence of a pulmonary embolism is indicated.

A system and method that provide a prophylactic treatment to a person, e.g., a patient, to avoid the occurrence of pulmonary embolisms by the system providing neuromuscular stimulation to a person's lower extremities, e.g., the person's legs, when the system senses that a person has been immobile for an extended period of time. An implantable neuromuscular pacer, such as that described in U.S. Pat. Nos. 5,193,539; 5,193,540; 6,164,284; 6,185,452; 6,208,894; 6,315,721; 6,564,807; and their progeny, may be used to provide to selectively provide such stimulation. Preferably, such a device may be battery powered so that it can operate independent of an external apparatus. In particular, systems and devices of the present invention preferably additionally include an activity monitor, e.g., an accelerometer or the like, that disables or limits stimulation to pronged time periods in which there is limited activity.

Disclosed herein are systems and methods to remove material of interest, including blood clots, from a body region, including but not limited to the circulatory system for the treatment of pulmonary embolism (PE), deep vein thrombosis (DVT), cerebrovascular embolism, and other vascular occlusions.

Retrievable vena cava filters for the temporary or permanent prevention of Pulmonary embolism (PE) are disclosed. A filter in accordance with the present invention has a tube-within-tube structure with overlapping semi-spheres. The semispheres comprise a plurality of expandable legs. The first tube may have a plurality of slots allowing for deployment of a first, second, third or fourth sets of expandable legs on the second tube. The free end of each leg in the first set of expandable legs is oriented in a direction opposite to the free end of each leg in the second set forming a cage which comprises legs from the first and second sets of expandable legs. The design of the present invention allows retrieval of the filter by a catheter and snare from either end of the filter.

A system and method for tree-model visualization for detecting an abnormality in an anatomical tree structure are provided. The method comprises: fitting a tree-model to an anatomical tree structure; converting branches of the tree-model into first two-dimensional branch images; and arranging the first two-dimensional branch images in a hierarchical order to form a second two-dimensional image.

Systems and methods can remove material of interest, including blood clots, from a body region, including but not limited to the circulatory system for the treatment of pulmonary embolism (PE), deep vein thrombosis (DVT), cerebrovascular embolism, and other vascular occlusions.

Fusion proteins comprising a single chain antigen-binding domain (scFv) of a monoclonal antibody, linked to an anti-thrombotic agent, anti-inflammatory agent, or a pro-drug thereof are provided, where the polypeptide binds to a binding site (antigen) expressed on the surface of a red blood cell at a density greater than 5,000 copies per red blood cell. Pharmaceutical compositions comprising these fusion proteins, and methods of delivering an anti-thrombotic agent to the surface of a red blood cell via delivery of these fusion proteins, and methods of treating or preventing thrombosis, tissue ischemia, acute myocardial infarction (AMI), ischemic stroke, cerebrovascular disease, pulmonary embolism, or ischemic peripheral vascular disease via administration of the fusion proteins or compositions comprising same are also provided.

The present invention relates to a device for filtering obstructive material within the vasculature of a subject. The device includes a generally ellipsoid shaped frame having a plurality of shape-memory arms with a collapsible, sieve-like structure positioned within the elliptical frame. The device may be used as an inferior vena cava (IVC) filter for the prevention of pulmonary embolism, or any other procedure requiring filtering of a vein.